Cerebral venous thrombosis in a patient with Crohn's disease

Patients with inflammatory bowel disease (IBD) have an elevated risk of venous thromboembolism compared with the general population. The most common sites of venous thromboembolism in IBD patients are the deep veins of the legs, the pulmonary system, and portal and mesenteric veins. However, cerebra...

Full description

Saved in:
Bibliographic Details
Published inIntestinal research Vol. 14; no. 1; pp. 96 - 101
Main Authors Cho, Young-Hak, Chae, Min Kyu, Cha, Jae Myung, Lee, Joung Il, Joo, Kwang Ro, Shin, Hyun Phil, Baek, Il Hyun, Jeon, Jung Won, Lim, Jun Uk, Hong, In Taik, Ki, Hye-Jin, Kang, Jae Bin
Format Journal Article
LanguageEnglish
Published Korea (South) Korean Association for the Study of Intestinal Diseases 2016
대한장연구학회
Subjects
Online AccessGet full text
ISSN1598-9100
2288-1956
DOI10.5217/ir.2016.14.1.96

Cover

More Information
Summary:Patients with inflammatory bowel disease (IBD) have an elevated risk of venous thromboembolism compared with the general population. The most common sites of venous thromboembolism in IBD patients are the deep veins of the legs, the pulmonary system, and portal and mesenteric veins. However, cerebral venous thrombosis is rarely associated with IBD. This report describes a case of cerebral venous thrombosis in a patient with Crohn's disease. A 17-year-old girl, diagnosed 4 years earlier with Crohn's disease, presented with headache and vomiting. Magnetic resonance imaging of the brain with venography showed venous thrombosis in the cortical veins, superior sagittal sinus, right transverse sinus, and right internal jugular vein. The patient immediately started anticoagulation therapy with intravenous heparin infusion followed by daily oral rivaroxaban 10 mg. Follow-up imaging after 2 weeks showed resolution of the thrombosis, with recanalization of the cortical veins, superior sagittal sinus, right transverse sinus, and right internal jugular vein. She continued rivaroxaban therapy for 6 months, and remained well, without neurologic sequelae. A high level of concern for cerebral venous thrombosis may be important when treating active IBD patients, because anticoagulation treatment can prevent fatal complications.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
G704-SER000010389.2016.14.1.008
ISSN:1598-9100
2288-1956
DOI:10.5217/ir.2016.14.1.96